The prognostic significance of ALDH1A1 expression in early
Aims: Aldehyde dehydrogenase family 1 member A1. (ALDH1A1) is reportedly a key ALDH isozyme linked to the cancer stem cells (CSC) of many solid tumours.
β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
23 juin 2014 We identified ALDH1A1 a cancer stem cell marker as being overexpressed in OC spheroids and directly connected to key elements of the ...
onc ?origin=ppub
A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence
15 juil. 2022 Ovarian cancer stem cells have a high expression of ALDH1A1 and patients with a high level of ALDH1A1 in their tumor have worse survival. Thus
ALDH1A1 in patientâ•'derived bladder cancer spheroids activates
ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Co-expression of cancer stem cell markers SALL4/ALDH1A1
https://ovarianresearch.biomedcentral.com/track/pdf/10.1186/s13048-021-00921-x.pdf
Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a
27 juin 2011 Abstract. Background: Aldehyde deyhdrogenase 1 (ALDH1) has been characterised as a cancer stem cell marker in different types of tumours.
Discrimination of Cancer Stem Cell Markers ALDH1A1 BCL11B
19 juil. 2021 Abstract: Cancer stem cells (CSCs) are accountable for the progress of head and neck squamous cell carcinoma (HNSCC). This exploratory study ...
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid
gies for malignant breast cancer. Significance: ALDH1A1 enzyme activity induces MDSC expansion and triggers a procancer immune microenvironment.
Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel
11 mars 2022 of aldehyde dehydrogenase 1A1 (ALDH1A1) expression in paclitaxel (PAC) and topotecan (TOP) resistant ovarian cancer cell lines.
A novel ALDH1A1 inhibitor blocks platinum-induced senescence
10 mai 2022 Mots clés : Cancer de l'ovaire ALDH1A1
. . . v .full
- aldh1a1 cancer stem cell
- aldh1a1 breast cancer
- aldh1a1 pancreatic cancer